Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Discloses 14.6% Stake in Artisan Partners Asset Management Inc. via Schedule 13G Amendment
BlackRock, Inc. has filed an Amendment No. 8 to Schedule 13G, reporting a beneficial ownership of 14.6% of Artisan Partners Asset Management Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 11.3% Stake in Acadian Asset Management
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 11.3% of Acadian Asset Management Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.3% beneficial ownership stake in LiveRamp Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 14.2% beneficial ownership stake in Stepan Co.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 16.1% Stake in Kaiser Aluminum Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 16.1% beneficial ownership stake in Kaiser Aluminum Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a beneficial ownership of 15.5% of Trinity Industries Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.8% Stake in M/I Homes, Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 15.8% of M/I Homes, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 9 to Schedule 13G, reporting a beneficial ownership of 15.2% of PJT Partners Inc.'s Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 10.2% of Sonic Automotive Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 14.4% of Glaukos Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has disclosed an increased passive beneficial ownership stake of 15.6% in SpartanNash Co, holding over 5.25 million shares as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its continued beneficial ownership of 11.7% of Graham Holdings Co's Class B Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, reporting a 14.7% beneficial ownership stake in Palomar Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.8% beneficial ownership stake in Xencor Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.4% Passive Stake in Frontdoor, Inc. Through Latest SEC Filing
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.4% beneficial ownership stake in Frontdoor, Inc. as of March 31, 2025, held in the ordinary course of business.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Independence Realty Trust, Discloses 14.4% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.4% beneficial ownership stake in Independence Realty Trust, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Kite Realty Group Trust, Disclosing 14.4% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, revealing a 14.4% beneficial ownership stake in Kite Realty Group Trust as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 16% Passive Stake in American Woodmark Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 16.0% passive beneficial ownership stake in American Woodmark Corp as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.0% Passive Stake in DNOW Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.0% beneficial ownership stake in DNOW Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Protagonist Therapeutics, Disclosing 14.8% Beneficial Ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 14.8% beneficial ownership stake in Protagonist Therapeutics, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 10.1% beneficial ownership stake in Harmony Biosciences Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.8% Stake in Watts Water Technologies Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.8% beneficial ownership stake in Watts Water Technologies Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.0% Stake in SiTime Corporation
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 12.0% in SiTime Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, reporting a 13.8% beneficial ownership stake in Thryv Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.4% Stake in Interface Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.4% of Interface Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.1% Stake in John B. Sanfilippo & Son Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.1% of the common stock of John B. Sanfilippo & Son Inc., totaling 1,366,496 shares as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 13.6% in Zurn Elkay Water Solutions Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a beneficial ownership of 13.8% of Lemaitre Vascular Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.1% beneficial ownership stake in TPG Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 11.7% of Azenta, Inc.'s common stock as of March 31, 2025.